The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

BACKGROUND: The use of a combination of the integrase inhibitor, cabotegravir, and the non-nucleoside reverse transcriptase inhibitor, rilpivirine, in a long-acting injectable form is being considered as an antiretroviral treatment option for people with HIV in sub-Saharan Africa. We aimed to model...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Glob Health
Hlavní autoři: Phillips, Andrew N, Bansi-Matharu, Loveleen, Cambiano, Valentina, Ehrenkranz, Peter, Serenata, Celicia, Venter, Francois, Pett, Sarah, Flexner, Charles, Jahn, Andreas, Revill, Paul, Garnett, Geoff P
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier Ltd 2021
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8050198/
https://ncbi.nlm.nih.gov/pubmed/33770513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2214-109X(21)00025-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky